Mitochondrial dysfunction and cellular senescence in ageing sarcopenia with current insights and targeted strategies
Molecular Biology Reports · 2026
DOI: 10.1007/s11033-026-11609-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Veepin Dwivedi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroscience, Smt. Kishoritai Bhoyar College of Pharmacy, New Kamptee, Rashtrasant Tukdoji Maharaj Nagpur University, Nagpur, 441002, Mah…. Hauptthemen laut MEDLINE: Sarcopenia, Cellular Senescence, Aging, Mitochondria. Die Arbeit nennt 86 Literaturangaben.
Abstract (Originalsprache)
Sarcopenia is a metabolic disorder characterized by the loss of muscle mass and function related to the aging process that adversely affects mobility, independence, and the burden of disease. Some of the key mechanisms associated with the loss of muscle mass and strength in sarcopenia, which have been referenced in the literature, are mitochondrial “dysfunction” and cellular “senescence,” which both cause muscle degradation. Mitochondrial dysfunction can lead to reduced production of ATP, increased oxidative stress, and inhibition of the muscle repair process. Cellular senescence impairs tissue homeostasis via mechanisms related to cellular senescence, including telomere shortening, inflammatory factors, and accumulation of senescent cells. The focus of this review is to elaborate on the complex interactions between aging and sarcopenia. Also, non-mitochondrial related mechanisms may further increase the loss of muscle due to the aging process, including astrocyte-derived pro-inflammatory cytokines, which have been shown to promote muscle atrophy during aging. There are several approaches to mitigate these outcomes using mitochondrial-specific antioxidants, exercise to enhance mitochondrial biogenesis, or utilizing senolytic approaches, some currently being investigated. In conclusion, these outcomes represent a review to assist in managing the multifactorial process of sarcopenia. Given sarcopenia, future work should also focus on establishing suitable biomarkers for identifying at-risk patients or establishing personalized approaches to managing and preventing loss of muscle and subsequent geriatric syndromes in association with loss of muscle. Addressing cellular aging and mitochondrial dysfunction may help maintain physical function and muscle health in older adults, enhancing their overall quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Neuroscience, Smt. Kishoritai Bhoyar College of Pharmacy, New Kamptee, Rashtrasant Tukdoji Maharaj Nagpur University, Nagpur, 441002, Maharashtra, India.
- Division of Neuroscience, Smt. Kishoritai Bhoyar College of Pharmacy, New Kamptee, Rashtrasant Tukdoji Maharaj Nagpur University, Nagpur, 441002, Maharashtra, India. shubhadamangrulkar@yahoo.com.
Zitieren
APA
Dwivedi, V., Thanekar, R., Khare, K., Taksande, B., Umekar, M., & Mangrulkar, S. (2026). Mitochondrial dysfunction and cellular senescence in ageing sarcopenia with current insights and targeted strategies. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-11609-0
Vancouver
Dwivedi V, Thanekar R, Khare K, Taksande B, Umekar M, Mangrulkar S. Mitochondrial dysfunction and cellular senescence in ageing sarcopenia with current insights and targeted strategies. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-11609-0
BibTeX
@article{Dwivedi2026,
author = {Dwivedi, Veepin and Thanekar, Rushikesh and Khare, Kanchan and Taksande, Brijesh and Umekar, Milind and Mangrulkar, Shubhada},
title = {Mitochondrial dysfunction and cellular senescence in ageing sarcopenia with current insights and targeted strategies},
journal = {Molecular Biology Reports},
year = {2026},
doi = {10.1007/s11033-026-11609-0}
}
EUVIMED